Myrbetriq® Medicare Coverage

Myrbetriq®
Chemical name: Mirabegron

Typical dosage: 50mg

Typical type: Tablet1

Myrbetriq® is a medication typically used to treat overactive bladder. It is available as brand only in the form of an extended release tablet.

Myrbetriq is a prescription medication that contains the active ingredient Mirabegron. It is taken once daily for the treatment of overactive bladder.

Myrbetriq activates beta receptors in the bladder, which increases the bladder capacity and decreases the urge to urinate.

The major side effects of this medication include headache, flu-like symptoms, dry mouth, back pain, dizziness, joint pain and constipation.

Does Medicare cover Myrbetriq?

Yes! 100% of Medicare Advantage plans and Medicare Part D plans cover Myrbetriq.1

  • Medicare Advantage plans that offer prescription drug coverage are called Medicare Advantage Prescription Drug Plans (MA-PD). Most Medicare Advantage beneficiaries (88 percent) are enrolled in MA-PDs.2

  • Medicare prescription drugs plans each have their own formulary, or drug list, that details what prescription drugs are covered by the plan and how they are covered.

Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Myrbetriq.

Find Medicare Advantage plans with drug coverage

Compare Plans

Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.

Average costs for Myrbetriq with Medicare drug coverage1

Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.

Deductible stage Typical copay stage
Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.

In the deductible stage, you’re responsible for the full cost of your prescription drugs.

Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.		 After you meet your Part D deductible, you enter the initial coverage period.

During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
$42 – $417 $25 – $417

Additional information

Myrbetriq may take up to 8 weeks to be fully effective. It may be used alone or in combination with other medications that also treat overactive bladder.

You can take Myrbetriq with or without food, but do not chew, break or crush the tablet. You should take this tablet with a full glass of water.

Myrbetriq has caused high blood pressure in some patients. You may have to check your blood pressure regularly while taking this medication.

Risks may be present when taking Myrbetriq while pregnant or breastfeeding.

 

 

This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.

Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.

Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.

1 GoodRx. Myrbetriq. Retrieved May 2019, from www.goodrx.com/myrbetriq.

2 Jacobson, Gretchen; et al. A Dozen Facts About Medicare Advantage. (Nov. 13, 2018). Kaiser Family Foundation. Retrieved from www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage.

MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.

Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.

Medicare has neither reviewed nor endorsed this information.